Whitepaper

Therapies Targeting Myeloid-Derived Suppressor Cells in the Tumor Microenvironment

Studying the tumor microenvironment (TME) helps improve our understanding of cancer. Myeloid-derived suppressor cells (MDSCs) exist within the TME and maintain cancer progression. MDSCs can be used as prognostic markers and potential therapeutic targets to eliminate immunosuppressive activities and enhance antitumor immune responses.

Download this whitepaper to learn more about immunotherapy strategies including:

  • Depletion of MDSC populations and infiltration
  • Inhibition of MDSC recruitment and transport
  • Anticytokine therapy of MDSCs

Download this whitepaper to learn more about immunotherapy strategies including:
  • Depletion of MDSC populations and infiltration
  • Inhibition of MDSC recruitment and transport
  • Anticytokine therapy of MDSCs

Download this Whitepaper for FREE Now!

Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.

Technology Networks Limited
Woodview | Bull Lane Industrial Estate | Sudbury | C010 0FD | UK
Email: privacy@technologynetworks.com
© 2022 Technology Networks. All rights reserved

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

This content is copyright protected. Any public or private use of this content is subject to prevailing copyright laws. Please contact Technology Networks for permission requests.